VANCOUVER, British Columbia, May 19, 2011 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today that the Company’s President and Chief Executive Officer, Dr. Mark J. Murray, will present at the ThinkEquity 2nd Annual Healthcare Conference on Wednesday, May 25, 2011 at 11:30 am Eastern Time at the Princeton Club in New York, NY. A webcast of the presentation can be accessed under the “Investors” section of Tekmira’s website at: www.tekmirapharm
